Spreading silence with Sid
© BioMed Central Ltd 2004
Published: 30 January 2004
RNA interference (RNAi) has been shown to spread from cell to cell in plants and in Caenorhabditis elegans, but it does not spread in other organisms, such as Drosophila. A recent report demonstrates that a membrane channel, encoded by the gene sid-1, is responsible for the spreading of RNAi between cells.
RNA interference (RNAi) is the phenomenon by which double-stranded RNA (dsRNA) sequences trigger the sequence-specific degradation of homologous endogenous mRNAs. RNAi was discovered serendipitously in 1998, when Andrew Fire and colleagues  were attempting to block gene expression by injection of antisense RNA into adult Caenorhabditis elegans. They discovered that the double-stranded RNA side-products of their RNA synthesis reactions were more effective inhibitors than single-stranded antisense RNA. Concentrated solutions of dsRNA have since become a potent experimental tool for inhibiting gene expression in C. elegans and other model organisms, including Drosophila.
RNAi in C. elegans has two striking characteristics. First, it is extremely specific and only targets mRNA sequences that are identical, not those that are closely related or highly homologous. Second, it is systemic: injection of dsRNA into the gut of a hermaphrodite individual allows gene suppression in most tissues of the animal, as well as effective suppression in most tissues of the animal's progeny. This 'spreading' characteristic underlies some of the most surprising observations in the short history of RNAi: namely that simply soaking worms in a solution of dsRNA , or feeding them transformed bacteria expressing dsRNA encoding a gene of choice , selectively suppresses the function of that gene in all of the individual's progeny. The latter 'feeding' induction technique has enabled successful large-scale genome-wide screens, in which banks of transgenic strains of Escherichia coli, each engineered to produce dsRNA for a single gene of the C. elegans genome, have been used to screen C. elegans genes for roles in embryonic development, genome stability, fat metabolism, longevity, and other biological processes [4–8].
As befits a pathway with such basic biological significance and such tremendous experimental potential, a great deal of recent work has gone into understanding the molecular mechanisms of RNAi. In the last five years great strides have been made in understanding the mechanisms by which dsRNA targets mRNA transcripts. The current picture (reviewed in [9, 10]) is that dsRNA is cleaved into fragments of 21-23 nucleotides by the Dicer family of RNAse III enzymes. These short dsRNA fragments are then incorporated into another enzyme complex, called the RNA-induced silencing complex (RISC). The antisense strand of the dsRNA fragment targets the homologous mRNA for cleavage. In contrast, however, surprisingly little is known about the mechanisms that allow the spreading of RNAi from cell to cell; for instance, it is not known what kind of molecule conveys the systemic RNAi signal, nor why some tissue types in C. elegans, such as the nervous system, are more resistant to systemic RNAi than others. Two recent publications from the Hunter lab [11, 12] have now made significant progress in this direction. The first contribution, from 2002 , describes a successful screening strategy for identifying genes involved in this non-autonomous spreading of RNAi. The second, appearing in September 2003 , characterizes one of these genes and shows that it encodes a putative channel protein that functions in the uptake of dsRNA across cell membranes.
Hunter and colleagues took a clever approach to identify genes supporting the non-autonomous effects of RNAi. They constructed a strain of C. elegans that visibly demonstrates both cell-autonomous and non-autonomous RNAi and screened for mutants in which non-autonomous RNAi fails but cell-autonomous RNAi persists. The strain, described by Winston et al. , is one in which expression of green fluorescent protein (GFP) is driven in the muscles of both the pharynx and the body wall. Expression of a dsRNA that targets and silences the GFP gene is then driven by a transgene construct that expresses a hairpin (double-stranded) RNA only in pharyngeal muscles. This dsRNA triggers suppression of GFP in pharyngeal muscles, demonstrating that cell-autonomous RNAi is still functional, but it also triggers partial suppression of GFP expression in body-wall muscles, demonstrating systemic spreading of RNAi. The authors  completely silenced all GFP expression in this strain by additionally feeding these worms on transformed E. coli expressing GFP dsRNA, further demonstrating non-autonomous RNAi. They then mutagenized the strain to identify progeny in which GFP expression was suppressed in pharyngeal muscles but retained body-wall muscles. In such strains, the loss of GFP in pharyngeal muscles should confirm that cell-autonomous RNAi mechanisms remain intact, while the persistent expression of GFP in body-wall muscles suggests that the RNAi no longer spreads systemically to neighboring cells. Three complementation groups of 'systemic RNAi-deficient' animals were identified using this approach, and the mutations were mapped to genetic loci called sid-1, sid-2, and sid-3.
The sid-1 gene encodes a 776-amino-acid protein with multiple stretches of hydrophobic amino acids, and Sid1-GFP fusion proteins concentrate at cell membranes . Together, these data suggest that the Sid-1 gene product functions as a membrane channel for an RNAi-inducing signal. Using a β-galactosidase protein-fusion assay, Feinberg and Hunter  have now shown that the amino terminus of Sid-1 is extracellular and that multiple hydrophobic sequences in Sid-1 indeed span the plasma membrane of expressing cells. A membrane channel for RNAi could conceivably function either in the export and/or in the import of an RNAi signal: demonstration that sid-1 is required cell-autonomously would indicate a function for the protein in the import of an RNAi signal, whereas demonstration that the protein functions non-cell-autonomously would be consistent with a role in export of RNAi. Hunter and colleagues addressed this issue in the original report describing the identification of sid-1 . Using an extrachromosomal transgene array driving mosaic expression of a sid-1-rescue transgene and a reporter construct encoding the red fluorescent protein DsRed in sid-1 mutants, they tested the ability of GFP expression in body-wall muscles to be repressed by exogenous GFP dsRNA. In these sid-1 mosaic animals, cells that were observed to have silenced GFP expression (indicating effective systemic RNAi) were found to be marked by DsRed, indicating that they also expressed functional Sid-1 from the extrachromosomal array, whereas neighboring cells in which GFP was not silenced (those resistant to systemic RNAi) all lacked Sid-1 expression . Thus, Hunter and colleagues  inferred that sid-1 is required for import of an RNAi signal. (The authors do not, however, exclude the possibility that sid-1 may also be required for export of an RNAi signal.)
In their more recent work, Feinberg and Hunter  have shown that sid-1 is not only required for systemic RNAi but is also sufficient when ectopically expressed to promote uptake of dsRNA in cultured cells of Drosophila. Flies lack an endogenous sid-1 ortholog, but despite this, Drosophila cells (such as the S2 cell line) are known to be susceptible to RNAi induced by dsRNA in their culture medium [13, 14]. Feinberg and Hunter  have shown, however, that S2 cells expressing Sid-1 showed equivalently effective RNAi of a luciferase transgene at dsRNA concentrations 10,000 times less than those required by cells lacking Sid-1 function. This effect appeared to be dependent on dsRNA length, as Sid-1 facilitated RNAi much more when cells were soaked in a solution of 500 base-pair (bp) dsRNAs than when they were soaked with 50 bp dsRNAs or 21 bp small interfering RNAs (siRNAs). Using a similar cell-culture assay, the authors  went on to show that Sid-1-mediated uptake of dsRNA probably takes place by a passive-diffusion mechanism: if transport were active it would be reduced in cold or energy-depleted conditions, but in fact the uptake of radiolabeled dsRNA by Sid-1-expressing S2 cells was affected by cold or ATP depletion less than the uptake of dsRNA by cells lacking functional Sid-1. Thus, the authors arrived at a model by which Sid-1 functions as a transmembrane channel protein, allowing passive diffusion of dsRNA into cells.
If RNAi functions as a primitive adaptive immune response, as has been postulated (discussed in ), then Sid-1 may clearly have a function in supplying cells with the dsRNA trigger for such a response. Consistent with such a role, endogenous Sid-1 in C. elegans appears to be expressed maximally in the cells that are exposed to the environment, such as those of the gut . Beyond natural roles for the protein, however, as Feinberg and Hunter  concluded, Sid-1-mediated dsRNA uptake may have numerous therapeutic and experimental applications. Experimentally, high-throughput dsRNA 'soaking' screens of cell lines  may be made more efficient by transgenic expression of Sid-1. Cell lines that are otherwise refractory to such a soaking approach may be made responsive by expression of Sid-1. Although RNAi induced by dsRNA transgenes in Drosophila is cell-autonomous and non-systemic , there is some evidence for the susceptibility of fly larvae to RNAi by soaking or ingesting dsRNA solutions  and for the susceptibility of adults to intra-abdominal dsRNA injection . Soaking or injection screens in Drosophila or other organisms that lack effective systemic RNAi, such as vertebrates, may be dramatically improved by creation of strains ubiquitously expressing exogenous Sid-1. Feinberg and Hunter  postulate that manipulating levels of Sid-1 in vertebrates may facilitate the future therapeutic use of RNAi to modulate gene expression in vivo. Such applications may depend on the size-dependence of dsRNA transport mediated by Sid-1, however, as longer dsRNA sequences provoke non-specific responses in vertebrate cells. Potential RNAi-based therapies have focused on the application of short siRNA sequences [20, 21]. Nonetheless, the description of sid-1 makes an extremely important contribution to our understanding of the systemic nature of RNAi in C. elegans, an under-researched aspect of this fundamentally important biological phenomenon. Characterization of Sid-2 and Sid-3 is eagerly awaited.
- Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC: Potent and specific genetic interference by double-stranded RNA inCaenorhabditis elegans.Nature 1998, 391:806–811.View ArticleGoogle Scholar
- Tabara H, Grishok A, Mello CC: RNAi inC. elegans: soaking in the genome sequence.Science 1998, 282:430–431.View ArticleGoogle Scholar
- Timmons L, Court DL, Fire A: Ingestion of bacterially expressed dsRNAs can produce specific and potent genetic interference inCaenorhabditis elegans.Gene 2001, 263:103–112.View ArticleGoogle Scholar
- Fraser AG, Kamath RS, Zipperlen P, Martinez-Campos M, Sohrmann M, Ahringer J: Functional genomic analysis ofC. eleganschromosome I by systematic RNA interference.Nature 2000, 408:325–330.View ArticleGoogle Scholar
- Pothof J, van Haaften G, Thijssen K, Kamath RS, Fraser AG, Ahringer J, Plasterk RH, Tijsterman M: Identification of genes that protect theC. elegansgenome against mutations by genome-wide RNAi.Genes Dev 2003, 17:443–448.View ArticleGoogle Scholar
- Ashrafi K, Chang FY, Watts JL, Fraser AG, Kamath RS, Ahringer J, Ruvkun G: Genome-wide RNAi analysis ofCaenorhabditis elegansfat regulatory genes.Nature 2003, 421:268–272.View ArticleGoogle Scholar
- Lee SS, Lee RY, Fraser AG, Kamath RS, Ahringer J, Ruvkun G: A systematic RNAi screen identifies a critical role for mitochondria inC. eleganslongevity.Nat Genet 2003, 33:40–48.View ArticleGoogle Scholar
- Kamath RS, Fraser AG, Dong Y, Poulin G, Durbin R, Gotta M, Kanapin A, Le Bot N, Moreno S, Sohrmann M, et al.: Systematic functional analysis of theCaenorhabditis elegansgenome using RNAi.Nature 2003, 421:231–237.View ArticleGoogle Scholar
- Hutvagner G, Zamore PD: RNAi: nature abhors a double-strand.Curr Opin Genet Dev 2002, 12:225–232.View ArticleGoogle Scholar
- Hannon GJ: RNA interference.Nature 2002, 418:244–251.View ArticleGoogle Scholar
- Winston WM, Molodowitch C, Hunter CP: Systemic RNAi inC. elegansrequires the putative transmembrane protein SID-1.Science 2002, 295:2456–2459.View ArticleGoogle Scholar
- Feinberg EH, Hunter CP: Transport of dsRNA into cells by the transmembrane protein SID-1.Science 2003, 301:1545–1547.View ArticleGoogle Scholar
- Caplen NJ, Fleenor J, Fire A, Morgan RA: dsRNA-mediated gene silencing in culturedDrosophilacells: a tissue culture model for the analysis of RNA interference.Gene 2000, 252:95–105.View ArticleGoogle Scholar
- Clemens JC, Worby CA, Simonson-Leff N, Muda M, Maehama T, Hemmings BA, Dixon JE: Use of double-stranded RNA interference inDrosophilacell lines to dissect signal transduction pathways.Proc Natl Acad Sci USA 2000, 97:6499–6503.View ArticleGoogle Scholar
- Gitlin L, Andino R: Nucleic acid-based immune system: the antiviral potential of mammalian RNA silencing.J Virol 2003, 77:7159–7165.View ArticleGoogle Scholar
- Kiger A, Baum B, Jones S, Jones M, Coulson A, Echeverri C, Perrimon N: A functional genomic analysis of cell morphology using RNA interference.J Biol 2003, 2:27.View ArticleGoogle Scholar
- van Roessel P, Hayward NM, Barros CS, Brand AH: Two-color GFP imaging demonstrates cell-autonomy of GAL4-driven RNA interference inDrosophila.Genesis 2002, 34:170–173.View ArticleGoogle Scholar
- Eaton BA, Fetter RD, Davis GW: Dynactin is necessary for synapse stabilization.Neuron 2002, 34:729–741.View ArticleGoogle Scholar
- Dzitoyeva S, Dimitrijevic N, Manev H: Intra-abdominal injection of double-stranded RNA into anesthetized adultDrosophilatriggers RNA interference in the central nervous system.Mol Psychiatry 2001, 6:665–670.View ArticleGoogle Scholar
- Check E: Gene regulation: RNA to the rescue?Nature 2003, 425:10–12.View ArticleGoogle Scholar
- Wall NR, Shi Y: Small RNA: can RNA interference be exploited for therapy?Lancet 2003, 362:1401–1403.View ArticleGoogle Scholar